Price-to-Earnings Ratio

The price-to-earnings ratio is the cornerstone of stock valuation, giving investors an at-a-glance sense of whether a stock is cheap or expensive relative to its earnings power. It divides the current share price by the earnings per share (EPS) over a given period, yielding a single number that can be compared across companies, sectors, or the broader market. A P/E of 20, for example, means investors are paying $20 for every $1 of annual earnings.

There are two common flavors of P/E. The trailing P/E uses actual reported earnings from the past four quarters, making it backward-looking but grounded in audited numbers. The forward P/E uses analyst consensus estimates for the next twelve months, which introduces uncertainty but gives a more current view of valuation. Both are useful, and sophisticated investors look at both together.

As of early 2025, Apple (AAPL) typically trades at a trailing P/E in the 28-35 range, reflecting investors' confidence in its ecosystem, services revenue growth, and fortress balance sheet. By contrast, a mature utility company might trade at a P/E of 14-16, while a high-growth software company might command a P/E north of 50. These differences reflect expected growth, business quality, and risk profile.

Context is everything when reading a P/E ratio. Comparing Apple's P/E to that of a regional bank is meaningless; the comparison only has weight within the same industry or against the company's own historical average. The S&P 500's long-run average P/E has historically hovered around 15-17, so a market-wide P/E of 25 or more signals elevated expectations for future earnings growth.

One limitation of the P/E ratio is that it is useless for companies with negative earnings — startups and turnaround situations often have no earnings at all. Earnings can also be distorted by one-time charges, accounting treatments, or share buybacks, so analysts often adjust reported EPS to get a 'normalized' picture. Despite these caveats, the P/E ratio remains the first metric most investors check when sizing up a potential investment.

P/E in Practice: Investors use the P/E ratio as a starting point for relative valuation rather than a definitive buy or sell signal. Within the S&P 500, sector P/E ranges vary considerably — in early 2025, technology and consumer discretionary sectors traded at forward P/E multiples above 25, while energy and financials hovered in the 12-16 range. Tracking a company's P/E against its own five-year historical average is a practical sanity check: if Visa has historically traded at 25-30 times earnings and suddenly trades at 18, the gap is worth investigating to determine whether the business has structurally deteriorated or whether the market has temporarily over-reacted. Many institutional investors also screen for stocks trading at a discount to their sector median P/E as a first pass for potential value opportunities.

Limitations of P/E: The P/E ratio has meaningful blind spots beyond the negative-earnings problem. First, earnings per share can be engineered through share buybacks without any improvement in the underlying business — a company that shrinks its share count by 10% boosts EPS by roughly 11% mechanically. Second, GAAP earnings are subject to management discretion in areas like revenue recognition timing, warranty reserve estimates, and impairment decisions, all of which can make reported earnings drift from economic reality. Third, the ratio is backward-looking when using trailing figures and requires accurate forecasts when using forward estimates — both carry risk. Finally, P/E ratios are sensitive to interest rate environments: when Treasury yields rise, the present value of future earnings falls, which compresses fair-value P/E multiples across the market. The 2022 rate-hiking cycle, which pushed the 10-year Treasury yield from under 2% to above 4%, drove meaningful P/E compression across growth stocks as the discount rate embedded in equity valuations rose sharply.

Cyclically Adjusted P/E (CAPE): The cyclically adjusted price-to-earnings ratio — developed by Nobel laureate Robert Shiller of Yale and sometimes called the Shiller P/E or CAPE — addresses one of the standard P/E's most significant limitations: its sensitivity to the current phase of the earnings cycle. The CAPE divides the current price of the S&P 500 by the average of ten years of inflation-adjusted earnings, smoothing out the cyclical peaks and troughs that distort single-year earnings figures. By using a decade of earnings history rather than the most recent year, the CAPE provides a longer-horizon perspective on whether the market is cheap or expensive relative to normalized earning power. Historically, the S&P 500 CAPE has averaged around 16-17 times since the late 1800s. Readings above 30 have historically been associated with below-average subsequent 10-year equity returns — the CAPE reached 44 at the peak of the dot-com bubble in early 2000, a level that preceded the 2000-2002 bear market, and climbed above 35 again in the early 2020s, drawing commentary from market historians about stretched valuations relative to long-run norms. Critically, while the CAPE has predictive power over long horizons (10 years or more), it is notoriously useless as a market timing tool over periods of months or years — markets can remain at high CAPE readings for extended periods before mean-reverting.

Sector P/E Norms: P/E ratios are not uniform across sectors, and applying market-average P/E expectations to any individual company without sector context is a common analytical error. Technology and software companies have historically commanded above-market P/E multiples because their asset-light models, high recurring revenue, and scalability support above-average growth and return on equity for extended periods. As of the mid-2020s, the technology sector of the S&P 500 typically traded at forward P/E multiples of 25-35, compared to the overall S&P 500 forward P/E of 18-22. Conversely, energy companies, which are subject to volatile commodity cycles and capital-intensive production economics, have historically traded at low-teens or even single-digit P/E multiples — not necessarily because they are cheap in any absolute sense, but because their earnings are both cyclically volatile and heavily influenced by commodity prices beyond management control. Financial companies, particularly banks, often trade at low-to-mid-teens P/E multiples because their earnings are sensitive to interest rate cycles and credit losses. Healthcare companies span a wide range, from high-growth biotech trading at triple-digit P/Es based on pipeline value to mature pharmaceutical companies at mid-teens multiples. Understanding these sector norms — and whether a specific company trades at a premium or discount to its sector — provides far more analytical insight than comparing any company's P/E to a single market-wide average.